Pot stocks are not winning any brownie points

The pot stocks aren't doing a great job of growing your capital.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are numerous cannabis-related stocks listed on the ASX. At this stage it's hard to say if or when any of the underlying businesses will become successful or not.

However, they are businesses just like any other listed on the ASX. The key thing that sustainably drives shares prices up is revenue growth and profit growth.

I wrote an article a month ago warning how the pot stock share prices had gotten way out of hand considering how early in the process of establishing medicinal cannabis is in Australia.

Since that article:

Auscann Group Holdings Ltd (ASX: AC8) is down 25%

Creso Pharma Ltd (ASX: CPH) is down 30%

MGC Pharmaceuticals Ltd (ASX: MXC) is down 17%

MMJ Phytotech Ltd (ASX: MMJ) is down 39%

Zelda Therapeutics Ltd (ASX: ZLD) is down 36%

I hope that the cannabis businesses do make a success of themselves, but investors have to be cautious about the price they pay for the earnings growth they are expecting. Otherwise, it is pure speculation which isn't a very good investment strategy and is just as likely to lose you a lot of capital.

I'd much rather invest in small speculative caps like National Veterinary Care Ltd (ASX: NVL), Fastbrick Robotics Ltd (ASX: FBR), Pureprofile Ltd (ASX: PPL) and SKY and Space Global Ltd (ASX: SAS) for long-term growth stories that could grow into large businesses.

Foolish takeaway

Pot stocks may yet recover and make some investors a quick buck. Personally, they don't appeal to me because their valuations are still high, they have no competitive advantage and they aren't making profits or paying dividends.

Instead, I'd rather get my investing highs from quality growth stocks like these three.

Motley Fool contributor Tristan Harrison owns shares of NATVETCARE FPO. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »